Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Clinical Trials: Overview01:11

Clinical Trials: Overview

2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Preclinical Development: Overview01:28

Preclinical Development: Overview

4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Clinical Trials01:16

Clinical Trials

6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.7K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

452
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
452
Drug Discovery: Overview01:26

Drug Discovery: Overview

7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

359
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
359

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effectiveness of preoperative pulmonary rehabilitation in patients with lung cancer combined with moderate to severe COPD: study protocol for a randomized controlled trial.

Respiratory medicine·2026
Same author

Clinical spectrum of pediatric-onset Erdheim-Chester disease: insights from a single-center case series.

Frontiers in pediatrics·2026
Same author

Using Plasma Amyloid Beta Oligomer to Screen in Alzheimer's Disease: A Pilot Study.

International journal of molecular sciences·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Non-linear association of admission platelet-to-lymphocyte ratio with 28- and 90-day mortality in critically ill patients with rheumatoid arthritis: a retrospective cohort study.

Clinical rheumatology·2025
Same author

Altered Cerebral Blood Flow in Type 2 Diabetes Mellitus Without Cognitive Impairment.

Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae·2025

相关实验视频

Updated: Jun 27, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K

通过无的2/3阶段试验设计加速疫苗开发.

Jia-Ying Yang1, Guo-Chun Li1, Ying Yuan2

  • 1Department of Public Health, School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.

Expert review of vaccines
|April 29, 2024
PubMed
概括

一个无的2/3阶段试验设计显著加速疫苗开发,减少试验持续时间和样本大小,同时保持有效性. 这种创新方法对于加快新疫苗,特别是多价值疫苗的批准至关重要.

科学领域:

  • 疫苗学 疫苗学 疫苗学
  • 临床试验设计 临床试验设计
  • 生物统计学 生物统计学

背景情况:

  • 传统的疫苗开发是漫长而昂贵的,涉及三个不同的阶段.
  • COVID-19疫苗的快速开发强调了加速批准流程的必要性.
  • 本文重点介绍了一种无的2/3期试验设计,以加快疫苗开发,特别是多价值疫苗.

研究的目的:

  • 为了比较一个无的2/3阶段设计与传统试验设计的性能.
  • 评估关键性能指标,包括功率,错误率,样本大小和试验持续时间.
  • 为了证明无设计的效率,使用模拟的9价值HPV疫苗试验.

主要方法:

  • 利用模拟来建模和比较试验设计.
  • 在三个不同的案例中评估了业绩.
  • 评估的指标包括总功率,I型错误率,平均样本大小,试验持续时间,早期停止百分比和剂量选择准确度等.

主要成果:

  • 使用临时疗效分析的无设计,平均减少了555.73名受试者的样本大小和10.29个月的试验持续时间,同时在疫苗有效时,功率增加了3.70%.
  • 当实验疫苗效率较低时,无设计平均挽救了887.73名受试者.
  • 在所有场景中,I型错误率始终保持在0.025以下.
关键词:
无二/三阶段试验同一初级终点的初级终点.有条件功率的条件功率.组序列设计组的设计.进行中期分析分析.

更多相关视频

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K

相关实验视频

Last Updated: Jun 27, 2025

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
09:03

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development

Published on: June 19, 2018

8.7K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.5K
Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

2.9K

结论:

  • 无的2/3阶段设计是疫苗开发的高效策略.
  • 这种设计通过早期停止,重新估计样本大小和缩短试验时间来提供多功能性.
  • 这种方法特别有利于加快多价值疫苗的开发和批准.